NanoViricides, Inc. Has Filed its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical ...

Posted 2024-11-15, Weatherford Democrat

SHELTON, CT / ACCESSWIRE / November 15, 2024 / SHELTON, CT / ACCESSWIRE / November 15,... read full story

Ask about this article

Answer for your question of the article will be displayed here ...

Related News

NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID

Pharmiweb 2024-11-15, 12:43

NanoViricides: Fiscal Q1 Earnings Snapshot

San Francisco Chronicle 2024-11-15, 01:04

High Roller Technologies Inc. Plans to File its Third Quarter Form 10 Q Form 8 K (High Roller Technologies Inc)

Public Technologies 2024-11-15, 19:57

Related News

Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q) (NanoViricides Inc)

Public Technologies
2024-11-15, 02:54

CleanCore Solutions, Inc. (ZONE) Reports First Quarter FY 2025 Financial Results and Provides Business Update Form 8 K (Cleancore Solutions Inc)

Public Technologies
2024-11-13, 15:01

Seabridge Gold Files Third Quarter 2024 Report to Shareholders and its Financial Statements and MD&A Form 6 K (Seabridge Gold Inc)

Public Technologies
2024-11-14, 21:50

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline

ACCESSWIRE
2024-11-14, 13:58

GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI 0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis Form 8 K (Gri Bio Inc)

Public Technologies
2024-11-14, 22:58

Late Filing Notice Form NT 10 Q (American Clean Resources Group Inc)

Public Technologies
2024-11-15, 19:57

Late Filing Notice Form NT 10 Q (American Acquisition Opportunity Inc)

Public Technologies
2024-11-15, 02:54

Late Filing Notice Form NT 10 Q (American Cannabis Company Inc)

Public Technologies
2024-11-14, 15:52